
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 5.41310541311 | 3.51 | 4.04 | 3.28 | 278817 | 3.68064833 | CS |
4 | 0.2 | 5.71428571429 | 3.5 | 4.19 | 3.28 | 196937 | 3.64041228 | CS |
12 | 0.494 | 15.4086088584 | 3.206 | 14.28 | 2.35 | 2075267 | 9.79274358 | CS |
26 | -3.02 | -44.9404761905 | 6.72 | 14.28 | 2.35 | 3636180 | 6.54677704 | CS |
52 | -8.046 | -68.4999148646 | 11.746 | 15.5386 | 2.35 | 1915786 | 6.80085452 | CS |
156 | -33.8144 | -90.137120679 | 37.5144 | 44.6544 | 2.35 | 649503 | 7.13352526 | CS |
260 | -205.74 | -98.2333842628 | 209.44 | 273.84 | 2.35 | 684534 | 68.68287519 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관